Generic drugs saved the U.S. healthcare system $3.4 trillion from 2015-2024. Learn how Hatch-Waxman, biosimilars, and market competition drive these massive savings and what challenges remain.
Feb, 25 2026
Dec, 4 2025
Jun, 17 2026
Oct, 17 2025
Jul, 14 2025